Botulinum toxin type A promotes microglial M2 polarization and suppresses chronic constriction injury-induced neuropathic pain through the P2X7 receptor

BACKGROUND: Switching microglial polarization from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype represents a novel therapeutic strategy for neuropathic pain (NP). This study aims to investigate whether botulinum toxin type A (BTX-A) regulates microglial M1/M2 polarization...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Biosci
Autors principals: Gui, Xianwei, Wang, Hansen, Wu, Lanxiang, Tian, Sheng, Wang, Xuan, Zheng, Heqing, Wu, Wei
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7092425/
https://ncbi.nlm.nih.gov/pubmed/32211150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13578-020-00405-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars